Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Girisopam is a novel selective benzodiazepine analog for the 2,3-benzodiazepine binding site, an atypical psychoanalytic with anxiolytic effects.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 130.00 | |
5 mg | In stock | $ 320.00 | |
10 mg | In stock | $ 480.00 | |
25 mg | In stock | $ 786.00 | |
50 mg | In stock | $ 1,080.00 | |
100 mg | In stock | $ 1,480.00 | |
500 mg | In stock | $ 2,960.00 |
Description | Girisopam is a novel selective benzodiazepine analog for the 2,3-benzodiazepine binding site, an atypical psychoanalytic with anxiolytic effects. |
In vivo | Girisopam (100 mg; oral; male subjects) After a 20-min delay, girisopam is rapidly absorbed. After reaching a mean serum level of 178 ng/ml at a mean time of 2.0 h, the serum concentration of girisopam decreased with a mean elimination half-time of 22.2 h.[1] |
Molecular Weight | 328.79 |
Formula | C18H17ClN2O2 |
CAS No. | 82230-53-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Girisopam 82230-53-3 inhibitor inhibit